NCT06662929 (PROMs) is a clinical trial of Radiation in Head and Neck Cancer, sponsored by King Saud University.

Who is sponsoring NCT06662929?

NCT06662929 is sponsored by King Saud University.

What drugs are being tested in NCT06662929?

Interventions in NCT06662929: Radiation.

What condition does NCT06662929 study?

NCT06662929 studies Head and Neck Cancer, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer, Nasopharyngeal Cancer, Oral Cancer, Tongue Cancer, Oral Neoplasm.

Is NCT06662929 still recruiting?

NCT06662929 is currently recruiting now. Last updated 29 October 2024.

Last reviewed 2024-10-29 · How we verify

NCT06662929: PROMs

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

Recruiting now Last updated 29 October 2024

What this trial tests

trial testing Radiation in Head and Neck Cancer in 125 participants. Currently enrolling.

Timeline

1 May 2023

Primary endpoint
1 June 2025

1 October 2025

Quick facts

Lead sponsor	King Saud University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	125
Start date	1 May 2023
Primary completion	1 June 2025
Estimated completion	1 October 2025
Sites	1 location across Saudi Arabia

Drugs / interventions tested

Radiation

Conditions studied

Head and Neck Cancer — all drugs for Head and Neck Cancer →
Head and Neck Neoplasms — all drugs for Head and Neck Neoplasms →
Head and Neck Squamous Cell Carcinoma — all drugs for Head and Neck Squamous Cell Carcinoma →
Oropharynx Cancer — all drugs for Oropharynx Cancer →

Sponsor

King Saud University

Who can join

18 and older, any sex, with Head and Neck Cancer or Head and Neck Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of Arabic patient-reported outcome measures during radiotherapy for head and neck cancer is to test the patient-reported outcome measure (PROM) tools. PROM tools are not validated cross-culturally in Arabic-speaking patient populations, which limits their use in our clinical setting. Validation of these PROM tools will allow clinicians to identify the concerns related to our patient population and measure the outcome of our interventions. Main objectives are: * To further validate (cross-culture) the PROM instruments related to head and neck cancer (HNC) in Arabic patients. * To investigate the prevalence and severity of the patient-reported concerns and their relevance with demographics and clinical characteristics. The participants will be given tasks to complete 6 tools survey before, during, and after radiotherapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Radiation

Trials testing the same drug.

NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · Phase 2 · not yet recruiting
NCT07141147 — A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Lo · NA · not yet recruiting
NCT06270888 — Hypofractionation (Radiation) Trial for Multiple Myeloma · Phase 1 · recruiting
NCT06875583 — The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study: The REDUCE Trial · NA · recruiting
NCT07046221 — Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery · Phase 2 · not yet recruiting

Other recruiting trials for Head and Neck Cancer

Currently open trials in the same condition.

NCT07318220 — Prehabilitation Protocol for Head and Neck Cancer Patients · NA · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07467083 — Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Unde · Phase 3 · recruiting
NCT07209189 — Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca · Phase 2 · recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema · NA · recruiting

Other King Saud University trials

Trials by the same sponsor.

NCT07500493 — Tele-Rehabilitation in Adults With Cystic Fibrosis · NA · not yet recruiting
NCT07324044 — Chrono-ALIGN: A Chronotype-Based Chrono-Nutrition Intervention in Post-Bariatric Patients · NA · not yet recruiting
NCT07288385 — Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Uppe · NA · recruiting
NCT07475195 — Oral Probiotics and Denture Care in Saudi Arabia: Evaluating Knowledge, Practices, and the Future of Innovative Hygiene · completed
NCT07159152 — Effects of Coffee Versus Hibiscus Tea Consumption During Prolonged Sitting on Blood Pressure and Heart Rate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06662929 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by King Saud University
Last refreshed: 29 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06662929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing